Skip to main content
Premium Trial:

Request an Annual Quote

Don't Wait Your Turn

One of DrugMonkey's readers relayed a bit of a situation. The reader is working on an R01 but a colleague who sits on a study section told the reader to "definitely wait two years so [the reader] can get things rolling before applying." DrugMonkey says that is nonsensical advice and that R01 funding is needed to get and keep a lab working and that waiting around isn't going to accomplish much. That little bit of extra preliminary data is not really going to affect your chance of receiving funding -- going through multiple grant cycles is common and other factors, such as reviewers' interest, also affect awards. DrugMonkey suspects this may be a case of bias against new PIs. "Strategically, I would say that if you just give up and accept this, there is zero chance of getting your award. If you submit anyway, at least you have a nonzero chance of someone like me being on the panel and arguing against this unjustified bias/tradition," he writes.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.